पदोन्नति कार्यक्रम Zenith Capital Corp.
उन्नत शेड्यूल
सरल ग्राफ
कंपनी के बारे में Zenith Capital Corp.
Zenith Capital Corp., a biotechnology investment company, engages in the development of bromodomain inhibitors for the treatment of cancer and other disorders with unmet medical needs. Its lead compound ZEN-3694 which is in Phase 2b clinical trials for the treatment of metastatic castration resistant prostate cancer and metastatic triple negative breast cancer. The company was formerly known as Zenith Epigenetics Corp. and changed its name to Zenith Capital Corp. in August 2016. The company was incorporated in 2013 and is headquartered in Calgary, Canada.| Industry | Biotechnology |
|---|---|
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.zenithepigenetics.com |
| Цена ао | 0.0001 |
| प्रति दिन मूल्य परिवर्तन: | 0% (0.0001) |
|---|---|
| प्रति सप्ताह मूल्य परिवर्तन: | 0% (0.0001) |
| प्रति माह मूल्य परिवर्तन: | 0% (0.0001) |
| 3 महीने में कीमत में बदलाव: | -99.8% (0.05) |
| छह महीने में कीमत में बदलाव: | -99.33% (0.015) |
| प्रति वर्ष मूल्य परिवर्तन: | -99.93% (0.15) |
| 3 वर्षों में मूल्य परिवर्तन: | -99.92% (0.121) |
| वर्ष की शुरुआत से मूल्य परिवर्तन: | -99.8% (0.05) |
|
|
बहुत मूल्यवान समझना
|
क्षमता
|
|||||||||||||||||||||||||||||||||||||
लाभांश
|
कर्तव्य
|
विकास का आवेग
|
|||||||||||||||||||||||||||||||||||||
| पर्यवेक्षक | नौकरी का शीर्षक | भुगतान | जन्म का साल |
|---|---|---|---|
| Mr. Donald J. McCaffrey | Chairman, President & CEO | 99.12k | |
| Mr. Aaron Bradley Cann C.A., CPA, CBV | CFO & Secretary | 42.54k | |
| Dr. Sanjay Lakhotia M.B.A., Ph.D. | Chief Business Officer | 317.15k | |
| Dr. Henrik Claus Hansen Ph.D. | Senior Vice President of Operations | 234.23k |
पता: Canada, Calgary. AB TE L, 4820 Richard Road SW - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.zenithepigenetics.com
वेबसाइट: https://www.zenithepigenetics.com
